A Novel Approach for a Novel Pathogen : Using a Home Assessment Team to Evaluate Patients for COVID-19
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization.
Errataetall: |
CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 16 vom: 19. Nov., Seite 2211-2214 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bryson-Cahn, Chloe [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 04.12.2020 Date Revised 14.12.2020 published: Print CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciaa256 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307544303 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307544303 | ||
003 | DE-627 | ||
005 | 20231225125809.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciaa256 |2 doi | |
028 | 5 | 2 | |a pubmed24n1025.xml |
035 | |a (DE-627)NLM307544303 | ||
035 | |a (NLM)32166310 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bryson-Cahn, Chloe |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Novel Approach for a Novel Pathogen |b Using a Home Assessment Team to Evaluate Patients for COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2020 | ||
500 | |a Date Revised 14.12.2020 | ||
500 | |a published: Print | ||
500 | |a CommentIn: Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. - PMID 32147715 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a Thousands of people in the United States have required testing for SARS-CoV-2. Evaluation for a special pathogen is resource intensive. We report an innovative approach to home assessment that, in collaboration with public health, enables safe evaluation and specimen collection outside the healthcare setting, avoiding unnecessary exposures and resource utilization | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a home assessment | |
650 | 4 | |a novel coronavirus | |
700 | 1 | |a Duchin, Jeffrey |e verfasserin |4 aut | |
700 | 1 | |a Makarewicz, Vanessa A |e verfasserin |4 aut | |
700 | 1 | |a Kay, Meagan |e verfasserin |4 aut | |
700 | 1 | |a Rietberg, Krista |e verfasserin |4 aut | |
700 | 1 | |a Napolitano, Nathanael |e verfasserin |4 aut | |
700 | 1 | |a Kamangu, Carole |e verfasserin |4 aut | |
700 | 1 | |a Dellit, Timothy H |e verfasserin |4 aut | |
700 | 1 | |a Lynch, John B |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 71(2020), 16 vom: 19. Nov., Seite 2211-2214 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2020 |g number:16 |g day:19 |g month:11 |g pages:2211-2214 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa256 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2020 |e 16 |b 19 |c 11 |h 2211-2214 |